Recordati (RECI)

Milan
Currency in EUR
Disclaimer
39.17
-0.07
(-0.18%)
Real-time Data
Day's Range
39.17
39.17
52 wk Range
34.52
49.83
Volume
1,469
Prev. Close
39.24
Open
39.17
Day's Range
39.17-39.17
52 wk Range
34.52-49.83
Volume
1,469
Average Volume (3m)
217,303
1-Year Change
-12.82%
Shares Outstanding
205,270,604
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
43.98
Upside +12.08%

People Also Watch

8.050
BMED
-1.30%
100.00
DIAS
+2.04%
12.96
BRBI
-0.54%
2.503
HRA
-0.71%
1.431
SRS
+0.77%

Recordati News

Recordati Company Profile

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

Employees
4303
Market
Italy